- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
SIGACHI
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Sigachi Industries Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
25.17 INR
-2.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 14.1% above the Trend Line and sits at 28.4% of its 52-week range. The latest completed week returned -2.9%, after a 11.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100.
Setup score
47
out of 100
Latest Close
25.17 INR
7 Aug 2026
1W Return
-2.9%
latest completed week
4W Return
11.0%
short-term follow-through
12W Return
24.3%
quarterly tape
Trend Breadth
3.8%
2 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.9%
Latest completed week; four-week move 11.0%.
Indicator stack
9/94
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
48/100
27 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 14.1% above the Trend Line and sits at 28.4% of its 52-week range. The latest completed week returned -2.9%, after a 11.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3212-week average 0.22
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.32Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.0% over four weeks, 24.3% over 12 weeks, and -22.2% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year2
Trend breadth3.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.94Latest activity-pressure read.
Pressure change108.9%Four-week change in activity pressure.
Leadership-8.42Latest relative-leadership reading.
RS change55.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value41/100Relative valuation strength. Underlying universe rank 60; rank 1 is best.
Quality23/100Profitability and accounting quality. Underlying universe rank 78; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth22/100Revenue and earnings growth. Underlying universe rank 79; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework49/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.9x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -3.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 51.9% Gross profit retained from each unit of revenue.
- Operating margin
- 11.4% Operating profit retained from revenue.
- Free-cash-flow margin
- -7.4% Free cash flow generated from revenue.
- Return on invested capital
- 6.4% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -2.1% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.4% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -3.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 27 relevant articles.
2 positive · 22 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-46.0%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+13.6%Week of 10 Apr.
Worst week-8.5%Week of 3 Jul.
Latest week-2.9%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains5
Flat weeks0
Modest losses4
Sharp losses9
Recent vol6.0%13-week weekly-return volatility.
Base vol8.7%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew7.1% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank- / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Drug Manufacturers - Specialty & Generic
4-week rank16 / 92
Group average1.0%
Trend breadth76.1%
Trend76.1%active weekly trend signals
MD80.4%positive activity pressure
RS65.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis39/100Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.32; No reversal markers Factors21/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 56; Small Cap Core rank 59 SVQF49/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 798.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 27 relevant articles.
Sigachi Industries Q1 Results: Earnings call scheduled for Aug 13 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 25.17 INR | -2.9% | 22.05 INR | 44.46 INR | 1.94 | -8.42 | 3.6M | On |
| 31 Jul 2026 | 25.92 INR | 1.6% | 22.21 INR | 44.51 INR | 1.71 | -5.46 | 4.7M | On |
| 24 Jul 2026 | 25.50 INR | 1.9% | 22.39 INR | 44.54 INR | 1.42 | -5.25 | 6.2M | Off |
| 17 Jul 2026 | 25.02 INR | 10.4% | 22.67 INR | 44.57 INR | 1.18 | -9.96 | 1.5M | Off |
| 10 Jul 2026 | 22.67 INR | -0.1% | 22.98 INR | 44.60 INR | 0.93 | -18.72 | 2.0M | Off |
| 3 Jul 2026 | 22.70 INR | -8.5% | 23.39 INR | 44.65 INR | 0.75 | -19.80 | 496.1K | Off |
| 26 Jun 2026 | 24.80 INR | 8.1% | 23.80 INR | 44.69 INR | 0.64 | -12.78 | 0 | Off |
| 19 Jun 2026 | 22.95 INR | 11.2% | 24.24 INR | 44.73 INR | 0.48 | -20.58 | 1.8M | Off |
| 12 Jun 2026 | 20.64 INR | -3.9% | 24.63 INR | 44.75 INR | 0.33 | -28.78 | 458.0K | Off |
| 5 Jun 2026 | 21.47 INR | 0.8% | 25.13 INR | 44.78 INR | 0.26 | -26.81 | 492.6K | Off |
| 29 May 2026 | 21.30 INR | 4.7% | 25.61 INR | 44.80 INR | 0.28 | -29.34 | 3.9M | Off |
| 22 May 2026 | 20.35 INR | 0.5% | 26.12 INR | 44.82 INR | 0.28 | -34.19 | 2.1M | Off |
| 15 May 2026 | 20.25 INR | -7.7% | 26.74 INR | 44.84 INR | 0.34 | -35.16 | 4.1M | Off |
| 8 May 2026 | 21.94 INR | 8.6% | 27.35 INR | 44.86 INR | 0.43 | -32.19 | 6.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.